|
WINNIPEG, MANITOBA--(Marketwired - Dec. 18, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that the Corporation has closed its previously announced non-brokered private placement offering (the "Offering") of a single unit (the "Unit") comprised of a $500,000 principal amount 2 year 10% convertible redeemable unsecured note (the "Note") and 4,000,000 share purchase warrants ("Warrants") for gross proceeds of $500,000. |
